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J.S. Weiss and B.E. Sumpio*Department of Vascular Surgery, Yale University School of Medicine, New Haven, CT, USAObjectives. Review the literature to determine the prevalence and outcome in patients with diabetes that undergo surgery to
correct carotid artery stenosis, lower extremity arterial disease, and abdominal aortic aneurysm (AAA).
Design and materials. Studies were obtained from searches over the past 15 years on the National Library of Medicine’s
online search engine.
Results. The review demonstrated an equivalent prevalence of carotid artery stenosis requiring surgery in patients with
diabetes, it favored no increase risk of post-CEA stroke, and it was split on perioperative morbidity and mortality risk. There
was an increase prevalence of lower extremity arterial disease requiring surgery in patients with diabetes, it favored
equivalent patency and limb salvage rates, and it was split on the morbidity and mortality risk. The review demonstrated a
decrease in AAA prevalence among patients with diabetes, it found an increase in the morbidity risk, and equivalent
mortality risk.
Conclusions. Stroke, graft patency, and limb salvage rates in patients with diabetes after surgery are similar to patients
without diabetes; however, their risk of complications is increased after surgery and the mortality risk may be higher after
CEA.Keywords: Diabetes; Carotid artery stenosis; Abdominal aortic aneurysm; Lower extremity arterial disease.Introduction
Diabetes mellitus affects approximately 7.8% of the
European population and afflicts 19% of all persons 60
years of age or older.1 There exists a 1.5 to 4.5-fold
increase in risk of myocardial infarction and a two-fold
increase in the risk of death in patients with diabetes.2
In fact, a patient with diabetes in his/her middle-age
can expect a 5–10 years reduction in lifespan.3
Cardiovascular disease is responsible for the majority
of this decrease in survival and accounts for over half
of all causes of death in diabetes.3 Surgical interven-
tion on various vascular conditions from atherosclero-
sis is instituted on both the patient with and without
diabetes. Comparison of the operative outcomes
between these groups will allow us insight intoing author. B.E. Sumpio, MD, PhD, Professor of
rgery, Department of Vascular Surgery, Yale-New
ital, Yale University School of Medicine, 333 Cedar
aven, CT 06520, USA.
: bauer.sumpio@yale.edu
0143 + 08 $35.00/0 q 2005 Elsevier Ltd. All rights reserthe clinical behavior of atherosclerosis in patients
with diabetes. The link between diabetes and athero-
sclerosis has been well studied, but the manifestation
of their pathogenesis is still not completely under-
stood. This paper will analyze carotid artery stenosis,
lower extremity arterial disease, and abdominal aortic
aneurysms (AAA) in patients with diabetes under-
going surgical correction to determine their prevalence
as well as outcomes after surgery.Methods
The literature review was performed using the
National Library of Medicine’s search engine, PubMed
(www.ncbi.nlm.nih.gov). Using a date range of January
1, 1990 to January 1, 2005, the limiting variables of
English-language, trials, and human studies were used.
The key words for the carotid artery stenosis review
were: carotid and diabetes, CEA and diabetes, carotid
artery endarterectomy and diabetes, diabetes andEur J Vasc Endovasc Surg 31, 143–150 (2006)
doi:10.1016/j.ejvs.2005.08.015, available online at http://www.sciencedirect.com onved.
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factors. Additionally, a search of all randomized
controlled trials using the key words carotid artery
endarterectomy was performed. The key words for the
lower extremity arterial disease review were: infra-
inguinal vascular disease and diabetes, infrageniculate
vascular disease and diabetes, extremity vascular
disease and diabetes, lower extremity bypass and
diabetes, and lower extremity bypass. The key words
for AAA review were: AAA and diabetes. The resulting
abstracts were manually screened for applicability and
at the minimum objectively analyzed diabetes with
respect to at least one of our chosen outcome measures.
The outcome measures for the carotid artery stenosis
analysis included post-CEA stroke, morbidity, and
mortality; for the lower extremity arterial disease
analysis it included postoperative graft patency, limb
salvage rates, morbidity, and mortality; and for the
AAA analysis it included prevalence, post-AAA repair
morbidity, and mortality. Additionally, the references
for each of the eligible studies in all sections were
scanned for relevant studies.
The eligible studies were formatted in tables for
comparison. Due to the heterogeneity of the endpoint
definitions, combining study numbers was deemed
inappropriate and not performed. EndovascularTable 1. Prevalence and outcome of patients with diabetes and carot
Study CEA (N) DM (%) Stroke
Kragsterman,4 2004 1518 13.8 NS
LaMuraglia,5 2004 2236 24.5 NS
Tu,6 2003 6038 23.1 NS*
Axelrod,7 2002 5522 40 NR
Bond,8 2002 1729 11.4 NS*
Pitolese,9 2001 781 24.7 NS
Kuhan,10 2001 741 11 [*#
Ballotta,11 2000 547 36.4 NS
Ahari,12 1999 2622 13 NS
Ferguson,13 1999 1415 NR NS*
Barnett,15 1998 1087 23 [*
Akbari,16 1997 732 39 NS
Riles,17 1994 3062 20 NS
Salenius,18 1990 331 12.1 [*
CEA, carotid endarterectomy; NR, not reported; NS, not statistically sign
mellitus.
Eur J Vasc Endovasc Surg Vol 31, 2 2006studies were intentionally excluded from our review;
their relatively recent entry into the literature provided
insufficient data to analyze diabetes as a separate
group. Statistical significance was defined as p!.05.ResultsCarotid artery stenosis
Fourteen papers were identified that examined
CEA against our chosen outcome measures (Table 1).
Three studies compared diabetes patients against all
three chosen outcomes; stroke, morbidity, and mor-
tality.9,11,16 The proportion of CEAs performed on
patients with diabetes ranged from 11 to 40%. All
studies analyzed stroke risk of patients with diabetes
against those without diabetes, except Ref. [7]. In five
studies, the stroke rate was combined with the
mortality rate and therefore, separate analysis on strict
stroke rate was not published.6,8,10,13,15 The time-frame
was indicated as up to 30 days in all studies except in
Refs. [16,17], in which the time-frame of perioperative
was used. Thirteen studies analyzed stroke rate, 10 of
these studies found that there was no increase in the
stroke rate for patients with diabetes undergoing CEA.id artery stenosis after CEA
Morbidity Mortality
(30 days)
Comments
NR [* *RR 2.03, p!0.002
NR [* *HR 1.356, p!0.011, 5.9 years
(mean)
NR [# *Combined death/stroke OR 1.28,
p!0.0435; # OR 2.13, p!0.0005
[* NS *Nonfatal cardiac events, 3.4 vs.
2.3%, pZ0.017
NR NS* *No [ in combined stroke and
death rates in DM pts
[* NS *3.1 vs. 0.8%, p!0.02 in combined
nonfatal cardiac and neurologic
events
NR [* *Combined stroke and death
rates, 9.8 vs. 3.2%; # RR 2.7,
pZ0.027, univariate only
NS [* *Cardiac-related deaths 6 vs. 1.7%,
pZ0.02, 44 months (mean)
NR [* *30 days: 3.2 vs. 1.4%, pZ0.02; 1
year: 7.9 vs. 4.4%, pZ0.008
NR NS* *Combined stroke and death
rates, adjusted RR 1.5, but NS
(NASCET14 data)
NR [* *Combined stroke and death rates
with RR 2.0, but only on univari-
ate analysis (NASCET14 data)
NS NS
NR NR
NR NS *20 vs. 8.2%, p!0.04
ificant; RR, risk ratio; HR, hazard ratio; OR, odds ratio; DM, diabetes
Table 2. Prevalence and outcome of patients with diabetes and lower extremity arterial disease after bypass
Study BPG (N) DM (%) Patency Limb sal-
vage
Morbidity Mortality Comments
AhChong,19 2004 265 66.4 NS NS [* [# *20 vs. 9% repeat debridements, pZ
0.04; #8 vs. 1%O30 days inpt mor-
tality pZ0.04
Grego,20 2004 71 77.4 NS* NS* NR NS* *Over 5 years span
Virkkunen,21 2004 5709 44 [* Y† [# NS *OR 0.8, p!0.01; †92.7 vs. 96.3%, p!
0.0001 at 30 days; #Infection OR 1.3,
p!0.001 and cardiac OR 1.5,
p!0.001
Wo¨lfle,22 2003 211 44.5 NS NS NS [* *22 vs. 5% at 1 year, pZ0.0004
Axelrod,7 2002 3838 55 NR NR [* NS *Nonfatal cardiac events 3.0 vs.
1.4%, pZ0.001
Calle-Pascual,23
2001
481 36.2 [* Y† [# [$ *Graft occlusions 2.1/year vs. 7.6/
year, p!0.05; # infection ratesOin
DM, p!0.05; †73.5 vs. 95.2% in fem-
distal bypass, p!0.01; $17.9 vs. 3.7%
at 3 years, p!0.05
Akbari,24 2000 962 82.6 NS* NS* NR NS*# *Over 5 years span; #30 days 0.
9%(DM) vs. 4.2%(NDM), pZ0.005
Bertele`,25 1999 1560 39.4 NR NS NR [* *RR 1.33 at 1 year
Gahtan,26 1998 170 55.3 NS* NS* NS NS* *Over 54 months span
Karacagil,27 1995 332 36.1 NS NS NS [* *Periop: 5 vs. 1.4%, p!0.001; 36
months: 38 vs. 14%, p!0.01
Dietzek,28 1990 987 62.9 NR Y* NR NR *p!0.05
BPG, bypass graft; NR, not reported; NS, not statistically significant; RR, risk ratio; OR, odds ratio; DM, diabetes mellitus.
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study from Salenius, et al.18 who found that patients
with diabetes had a 20% perioperative stroke rate vs.
an 8.2% risk in patients without diabetes. The other
two were not designed to look at stroke separately and
therefore, a combined death and stroke rate was
published.10,15 These rates were increased, but they
only provided a univariate analysis. Morbidity was
reported in four papers7,9,11,16 and was defined as the
combination of nonfatal neurologic (TIA or stroke) and
cardiac (MI or CHF) complications within 30 days of
surgery. Two studies failed to demonstrate a difference
in complications between patients with and without
diabetes;11,16 however, both Refs. [7,9] found that
patients with diabetes had a statistically significant
increase in complications. Early mortality was studied
in 12 papers4,6–13,15,16,18 and late mortality was studied
in three.5,11,12 Seven of twelve papers failed to show
an increase in the mortality rates of patients with
diabetes undergoing CEA;7–9,11,13,16,18 however, five
papers4,6,10,12,15 did show that patients with diabetes
were at an increased risk of early mortality. The three
papers that looked at late death all agreed that patients
with diabetes had higher late mortality. These papers
had mean follow-up ranging from 1 to 5.9 years.Lower extremity arterial disease
Eleven papers were identified that examined lower
extremity arterial disease against our chosen outcomemeasures (Table 2). Six papers evaluated all four of our
chosen outcomes; patency, limb salvage, morbidity,
and mortality.19,21–23,26,27 The proportion of lower
extremity bypasses performed on patients with
diabetes ranged from 36.1 to 82.6%. Eight papers19–24,
26,27 examined patency on bypass grafts with time-
frames ranging from 30 days to 5 years. Six studies
found no difference on patency when comparing
patients with and without diabetes.19,20,22,24,26,27 The
other two21,23 found increased patency among patients
with diabetes, one study examined early patency
(30 days)21 and the other late patency (5 years).23
Limb salvage was examined by all studies except Ref.
[7]. The time-frames studied varied from 30 days to 5
years, one study failed to indicate the time endpoint.28
Seven papers found equivalent limb salvage rates
among patients with diabetes when compared those
without diabetes.19,20,22,24–27 Three studies showed
decreased limb salvage rates;21,23,28 one of these
studies21 had the largest number of patients and the
shortest endpoint (30 days). Seven studies examined
morbidity,19,21–23,26,27 these studies differed in their
definition of morbidity, but all included
nonfatal cardiac causes. Three studies found no
difference,22,26,27 the other four7,19,21,23 demonstrated
increased morbidity in patients with diabetes, primar-
ily due to infection and nonfatal cardiac events. All but
one study28 analyzed mortality. Six of the ten
examined early mortality (!30 days).7,19,21,24,26,27
Five of these six showed no differences in mortality,
the outlier was Ref. [27]. Of the remaining fourEur J Vasc Endovasc Surg Vol 31, 2 2006
Table 3. Prevalence and outcomes in patients with diabetes and AAA after repair
Study AAA (N) DM % Prevalence Morbidity Mortality Comments
Rayan,29 2002 421 12.3 NR [* NS# *Overall NS, but pneumonia and pancrea-
titis higher in DM pts, p!0.006 and
p!0.013; #Overall NS, but DM pts reached
SS when suprarenal clamps excluded, 4.1
vs. 0.58%, pZ0.023
Singh,30 2001 263 NR NS NR NR
Shteinberg,31 2000 82 6 Y* NR NR *6 vs. 36% prevalence comparing DM pts
prevalence in AAA to AOD, p!0.001
Blanchard,32 2000 98 12 Y* NR NR *OR 0.32
Kang,33 1999 264 6.4 Y* NR NR *6.4% of DM with AAAS3 cm vs. 9.6%, OR
0.58 for AAAS3 cm in DM, pZ0.002
Dardik,34 1999 2335 7.2 NR NR NS* *3.0 vs. 3.5% (NDM), pZ0.95
Mattes,35 1997 303 2.3 Y* NR NR *Stated as lower, but no statistical analysis
Lederle,36 1997 3366 12 Y* NR NR *12% AAA with DM vs. 19% without AAA
with DM, p!0.001; OR 0.68 for 3–3.9 cm
AAA, 0.54 forS4 cm
Kanagasabay,37
1996
218 5 NS* NR NR *OR 0.8, pZ0.5
Pleumeekers,38
1995
91 8.6 NS NR NR
LaMorte,39 1995 4682 5.3 Y* NR NR *OR 0.78, pZ0.03
Simoni,40 1995 70 14.1 NS* NR NR *1504 pts screened, 14.1% of normal aortas
with DM and 14.1% of AAAs with DM,
pZ0.964
Tremain,41 1994 568 7 NR [* NS *Increased myocardial infarction and
wound infection rates, but analysis
included subset of aortic occlusive disease
patients
Katz,42 1994 10014 5.1 NR NR NS* *6.7, 7.6%(NDM), pZ0.6
Smith,43 1993 219 5 NS NR NR
NR, not reported; NS, not statistically significant; AOD, aortic occlusive disease; DM, diabetes mellitus; NDM, non-diabetic.
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6 months to 5 years. Three of these four demonstrated
increased mortality in patients with diabetes, the
outlier was Ref. [20] which had the smallest number
of patients and longest follow-up.Abdominal aortic aneurysm
Fifteen papers were identified that examined abdomi-
nal aortic aneurysms against our chosen outcome
measures (Table 3). No study evaluated all our chosen
outcomes; prevalence, morbidity, and mortality. The
proportion of AAA repaired in patients with diabetes
ranged from 2.3 to 14.1%, this range includes Ref. [33]
that screened patients based on the presence of carotid
artery stenosis. Eleven studies analyzed the preva-
lence of AAA in patients with diabetes30–33,35–40,43 Six
papers31–33,35,36,39 found a lower prevalence of AAA in
patients with diabetes and five papers30,37,38,40,43
found no difference in the prevalence. The two largest
studies found a lower prevalence,36,39 but they shared
data from the Veteran Affairs’ Aneurysm Detection
and Management trial.44 Of the studies that did not
show a difference in prevalence, Ref. [30] did not
provide statistical evidence and Ref. [40] had the
smallest number of patients. Only two studiesEur J Vasc Endovasc Surg Vol 31, 2 2006examined the inpatient morbidity following AAA
repair in patients with diabetes.29,41 Both studies
found through subset analysis that these patients
had increased risk for certain complications. Ref. [41]
included a subset of aortic occlusive disease patients in
their analysis, but found increased myocardial infarc-
tion and infection rates. Ref. [29] found overall
complications to be similar between patient groups,
but that patients with diabetes had higher rates of
pneumonia and pancreatitis. Mortality was analyzed
in four papers,29,34,41,42 including the study with the
largest number of patients.42 All papers agreed that no
difference exists in the mortality between patients with
diabetes and those without diabetes undergoing AAA
repair.Discussion
The aim of this review was to illustrate the differences
in the pathophysiology of atherosclerosis by summar-
izing the prevalence and clinical outcomes of vascular
disease in patients with diabetes against patients
without diabetes. The results of all sections were
scored based not only on the direction of outcome, but
also on the merit and weight of the study (Table 4).
Table 4. Prevalence and outcome summary
CAS LEAD AAA
Stroke z
Patency G[
Limb Salvage GY
Prevalence z [ Y
Morbidity G[ G[ [
Mortality G[ z z
z, equivalent; Y, decreased; [, increased; G, slight.
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The majority of patients in the three groups of vascular
pathologies analyzed in this study were older than 60
years of age, the prevalence of diabetes in this age
group is estimated to be 19%.1 After establishing this
percentage as our baseline, we determined each
groups’ proportion of patients with diabetes that
underwent operations. We observed that these
patients account for anywhere from 11 to 40% of all
CEAs studied, 36.1–82.6% of lower extremity
bypasses, and 2.3–14.1% of AAA repairs. Patients
with diabetes have been shown to have about 1.4–1.7
the relative risk of stroke.45 The increase in risk may be
attributed to more than just the severity of carotid
artery stenosis as patient with diabetes are at increased
risk for lacunar and cardioembolic stroke.46 The
published prevalence of carotid artery stenosis varies
depending on the definition of significant carotid
artery stenosis. Ramsey, et al.47 found a 5.9% preva-
lence of carotid artery stenosis O40% among the older
than 50 age group, which is similar percentage in a
larger study by Hennerici, et al.48 Fowl, et al.49 who
defined significant carotid artery stenosis as O50%
studied an asymptomatic population and found a
prevalence of 6.5%, but they also demonstrated that
diabetes was not a risk factor for developing carotid
artery stenosis. We found that the prevalence of
diabetes fell within the range of proportions of
patients with diabetes undergoing CEA by age
group. Therefore, it appears likely that the prevalence
of operable carotid artery stenosis is not increased in
patients with diabetes despite their increased risk of
stroke.
Clearly there exists a higher prevalence of surgical
correction of lower extremity arterial disease in
patients with diabetes, which one could conclude is
because of a higher prevalence of lower extremity
arterial disease. This conclusion is supported by many
studies, one of which is from the National Health and
Nutrition Examination Survey. This report established
a lower extremity arterial disease prevalence of 3.6%
in patients without diabetes compared to 10.8%
in patients with diabetes aged 40 years or older.50On a fully adjusted model, they found the odds ratio to
be over double that of patients without diabetes for the
development of lower extremity arterial disease.
Equally as convincing, but trending in the opposite
direction is the prevalence of AAA in patients with
diabetes. Our analysis demonstrates the prevalence
range of AAA to be much lower than the overall
prevalence of diabetes. Even though our data favored
a lower prevalence of AAA in patients with diabetes,
all studies were not in agreement with this con-
clusion;30,37,38,40,43 however, no study showed an
increase in prevalence. The finding of a lower
prevalence of AAA in patients with diabetes is
perhaps the most intriguing in our review and is in
agreement with the current theories on the pathogen-
esis of AAA on a cellular level,51 which is distinct from
atherogenesis.52 Some investigators hypothesize that
there is an increase in wall stiffness in patients with
diabetes, which could explain in part the lower
prevalence of AAA.53 Furthermore, up-regulation of
matrix metalloproteinases (MMP) has been implicated
in the pathogenesis behind AAA formation. Research-
ers have studied matrix metalloproteinases in diabetic
arteries and found down-regulation in the expression
of extracellular matrix inducer proteins with a two-
fold reduction of total MMP activity.54 Decreases in
MMP activity could contribute to increased collagen
deposition which would lead to remodeling and
extracellular matrix deposition in the diabetic vascu-
lature. This could also explain the decrease in
prevalence of AAA in patients with diabetes that we
have demonstrated and underscores the counter-
theory that AAA formation is not directly causally
linked to atherosclerosis.Morbidity
When examining the morbidity of these vascular
procedures, we found consistent increases in dia-
betes patients. This parameter had the greatest
heterogeneity between studies and was often least
reported. Nonfatal cardiac events and infection were
the most frequent subcategories that reached statisti-
cal significance. The morbidity in CEA favored
equivalency between patient with and without
diabetes, only Refs. [7,9] found an increase in
combined nonfatal MI and neurologic events. The
lower extremity arterial disease bypass studies were
evenly split between groups. When differences
existed, infection and nonfatal MI accounted for the
majority of morbidity. Finally, when examining AAA,
both studies that examined morbidity found an
increase in infectious complications.Eur J Vasc Endovasc Surg Vol 31, 2 2006
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of operation increased, a consensus on morbidity was
observed. A subcutaneous operation often performed
under local anesthesia, such as a CEA, may not pose
enough stress to consistently show differences in
morbidity. The advances in pre-operative work-up
and perioperative management have decreased the
number of cardiac events, so it is not unexpected that
infection was the leading cause of morbidity in
patients with diabetes.55 Cruse, et al.56 examined
surgical wound infections of 23,649 patients under-
going various procedures and found the unadjusted
clean wound infection rates were 10.7 and 1.8% in
patients with diabetes and those without, respectively.
The increased wound infection rates were best
illustrated in the lower extremity arterial disease
studies. In all three studies that indicated a higher
infection rate, patient with diabetes presented with a
higher percentage of tissue loss.Mortality
Population studies have shown that the risk of death
in a patient with diabetes is twice that of age-matched
and co-morbidity adjusted patient without diabetes;2
70% of these deaths are caused from cardiovascular
disease. This paper primarily examined surgical
mortality. Studies in our review that did examine late
mortality consistently found higher mortality in
patients with diabetes.5,11,12,19,20,22,23,26,27 In lower
extremity arterial disease bypass and AAA repair
patients, mortality appears equivalent between
groups. This suggests that the atherosclerotic process
driving the development of clinical disease may
override the effect of diabetes. Patients with diabetes
undergoing surgery for lower extremity arterial
disease may have comparable cardiac atherosclerotic
burden as patients without diabetes and therefore
similar risks; this may also be true for both groups
undergoing AAA repair. Patients with diabetes under-
going CEA were found to have an increased mortality
risk in almost half of the studies. At first glance, it
seems counter-intuitive that an operation posing the
least stress would cause the most mortality; however,
it has been shown that patients with diabetes have
worse outcome with stroke than patients without
diabetes.57,58 Patients with diabetes have impaired
autoregulation of cerebral blood flow along with
rheological changes in erthyrocytes.57 The increase in
mortality is also thought to be associated with
hyperglycemia from anaerobic glycolysis of excess
glucose.59 Fatal strokes could account for some of the
increased mortality, but it could also be that patientsEur J Vasc Endovasc Surg Vol 31, 2 2006with diabetes undergoing CEA have more extensive
coronary artery disease than patients without diabetes.
Increased carotid artery intima and media thickness
(IMT), a potential surrogate measurement of coronary
atherosclerosis, has been shown to be a risk factor for
myocardial infarction.60 Diabetes patients have been
found to have higher internal carotid artery IMT
measurements, both at baseline and with pro-
gression.61,62 Total carotid plaque burden (TPB),
which measures intimal thickness only, is also higher
in patients with diabetes.63 This non-invasive study
correlates with the finding of longer ICA plaques
during CEA in patients with diabetes.9 Both IMT and
TPB correlate with higher stroke and myocardial
infarction rates, patients with the highest measure-
ment groups have nearly three times the relative
risk.60,63 Other studies have found diabetes to be
closely associated with TPB, but not carotid artery
stenosis.64 Taken together, findings support our
observation that the prevalence of carotid artery
stenosis is not increased in patients with diabetes
undergoing correction. Additionally, it could explain
some of the increased cardiac risk of patients with
diabetes, since their carotid artery stenosis may be a
more aggressive form of atherosclerosis than patients
without diabetes. This conclusion, is supported by a
study that found diabetes patients with carotid artery
stenosis had the highest hazard ratio of all risk factors
tested for severe MI or death.65Conclusion
Through, this review of the literature we demonstrate
the differences and similarities in prevalence and
outcome of patients with diabetes as compared to
patients without diabetes undergoing common vas-
cular procedures. Our subjective conclusions are
summarized concisely in Table 4. With regards to
prevalence, we conclude that it is equivalent in carotid
artery stenosis, increased in lower extremity arterial
disease, and decreased in AAA in patients with
diabetes. Stroke, graft patency, and limb salvage
rates in patients with diabetes after surgery are similar
to patients without diabetes, but perioperative com-
plication risks were increased in all surgical groups.
The perioperative mortality risk may be higher after
CEA, this risk may be related to the specific effects of
diabetes on the cardiac vasculature. We have also
observed biological differences of the atherosclerosis
phenotype in patients with diabetes. It is these
differences that could account for the disaccord in
outcome when comparing two similar diseases in two
dissimilar patient groups. Further study into
Diabetes and Vascular Disease 149the phenotype of diabetic atherosclerosis may help to
elucidate its natural history and provide guidance on
when and how to intervene.References
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